10/02/2026
It's Flagship Friday and we are so excited to introduce you to one of our longtime supporters Alkermes!
Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder and narcolepsy. Alkermes’ pipeline includes late-stage clinical candidates in development for narcolepsy and idiopathic hypersomnia, and orexin 2 receptor agonists in early clinical development for other neurological disorders, including attention-deficit hyperactivity disorder (ADHD) and fatigue associated with multiple sclerosis and Parkinson’s disease. Headquartered in Ireland, Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio. For more information, please visit Alkermes’ website at www.alkermes.com
You can meet the Alkermes team in the Exhibit Hall at the VASAM 2026 Annual Conference, to be held October 23-24, 2026, at the Hilton Norfolk - The Main. If you haven't done so yet, head over to our website, checkout our amazing speakers and networking opportunities and register today!
www.vasam.net/conference